Inflammatory Demyelinating Pseudotumor in the Spinal Cord is a Rare Thing

Inflammatory demyelinating pseudotumor usually occurs in the brain, it rarely occurs in the spinal cord.

On imaging, inflammatory demyelinating pseudotumor appears very similar to intramedullary tumors such as gliomas. It is often misdiagnosed as intramedullary tumor and surgically resected.

Microbes in the Gut Help Determine Risk of Tumors, Says Study
A new study finds transferring the gut microbes from a mouse with colon tumors to germ-free mice makes those mice prone to getting tumors as well.

In view of this, the clinical and magnetic resonance imaging manifestations and the pathological features of 36 cases of inflammatory demyelinating pseudotumor in the spinal cord were retrospectively analyzed and summarized by Ying Wang and colleagues from Department of Neurology, Yantai Shan Hospital, China. They found that tumor-like inflammatory demyelinating disease in the spinal cord is a kind of special demyelinating disease that can be categorized as inflammatory pseudotumor. These solitary lesions are easily confused with intramedullary neoplasms.

Patchy or non-closed reinforcement (open-ring sign) on magnetic resonance imaging is the predominant property of inflammatory demyelinating pseudotumor, and inflammatory cell infiltration and demyelination are additional pathological properties. This study, published in the Neural Regeneration Research (Vol. 8, No. 26, 2013), summarizes the clinical and imaging properties of inflammatory demyelinating pseudotumor in the spinal cord, aiming to decrease the misdiagnosis rate in the clinic and improve patients' quality of life.

Source-Eurekalert

Scientists Are Exploring Whether Malignant Neural Stem Cells Give Rise To Brain Tumor Stem Cells
It is believed that glioma is derived from brain tumor stem cells. Despite this, the source and molecular signal pathways of these cells are still unclear.

Scientists Discover 2 Types of Bone Tumor Defined By Novel Mutations
A rare discovery was made by scientists that allows them to attribute two types of tumour almost entirely to specific mutations that lie in two related genes.

Mechanisms and Potential Biomarkers of Tumor Cell Dormancy Identified
Oncologists have long puzzled over the fact that after cancer treatment, in certain organs, single cancer cells that are dispersed throughout the body – so-called disseminated tumor cells – are quick to grow and form secondary tumors called metastases.